HOME > BUSINESS
BUSINESS
- Daiichi Sankyo Selling Takatsuki Plant to Taiyo for 37.6 Billion Yen
February 1, 2019
- Ono Grabs Asian Rights to Repare’s Pol-theta Inhibitor
February 1, 2019
- JT Files Topical JAK Inhibitor in Japan for Atopic Dermatitis
February 1, 2019
- FDA Nixes Sunovion’s Parkinson’s Drug, but Requires No New Studies
February 1, 2019
- Fycompa Filed for Monotherapy, Pediatric Use in Japan: Eisai
January 31, 2019
- Merck Serono Files Bavencio in Japan for First-Line Use in RCC
January 31, 2019
- Takeda’s Tetravalent Dengue Vaccine Succeeds in PIII Study
January 31, 2019
- Chugai to Transfer Japan Rights for 3 Topical Maxacalcitol Products to Maruho
January 31, 2019
- Kymriah Study Drugs to Be Manufactured in Kobe: Novartis
January 30, 2019
- Stem Cell Therapy SB623 Misses Key Target in US PIIb Study for Stroke: SanBio, Sumitomo Dainippon
January 30, 2019
- Protosera, Fujita Health Univ. Tie Up for Research to Develop Treatments for Autism Spectrum Disorder
January 30, 2019
- China Approves Latuda for Schizophrenia: Sumitomo Dainippon
January 30, 2019
- Takeda to Book 38 Billion Yen Gain from Sale of Osaka HQ, Other Assets
January 29, 2019
- Ex-MHLW Bureau Chief Takeda Tapped as Senior Adviser at BCG
January 29, 2019
- Nippon Express to Set Up 4 Distribution Centers for Full-Scale Drug Logistics Biz, Aims for 15 Billion Yen Annual Sales
January 29, 2019
- Xofluza Enjoys Commanding Lead with 47% Share in October-December, MHLW Data Show
January 28, 2019
- Tamiflu Generics, Too, in Tight Supply amid Spike in Flu Patients
January 28, 2019
- Sun Pharma Poised to Raise Profile in Japan Dermatology Space, Generics and New Drugs Alike
January 25, 2019
- Takeda’s Specialty Business Unit Boots Up with Entyvio Detailing
January 25, 2019
- Shionogi, PeptiDream Join Forces for Novel Peptide Drug-Conjugate Discovery Research
January 24, 2019
ページ
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
